SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20FR12G/A - Registration of securities [Section 12(g)]: [Amend]
SEC Accession No. 0001144204-05-027316
Filing Date
2005-08-29
Accepted
2005-08-29 11:49:02
Documents
7

Document Format Files

Seq Description Document Type Size
1 v024911_20fr12ga.htm 20FR12G/A 2679140
2 v024911_ex4-1.htm EX-4.1 241031
3 v024911_ex4-2.htm EX-4.2 149295
4 v024911_ex4-6.htm EX-4.6 126583
5 v024911_ex15-1.htm EX-15.1 4282
6 v024911_ex15-2.htm EX-15.2 5812
7 filename7.htm CORRESP 9766
  Complete submission text file 0001144204-05-027316.txt   3217256
Mailing Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3 00000
Business Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 20FR12G/A | Act: 34 | File No.: 000-51310 | Film No.: 051053965
SIC: 2834 Pharmaceutical Preparations